Evidence map›Paper›PMID 30575033›Full record

ArticleJournal of cellular physiology2019

AdoMet triggers apoptosis in head and neck squamous cancer by inducing ER stress and potentiates cell sensitivity to cisplatin.

Laura Mosca, Martina Pagano, Concetta Paola Ilisso, Donatella Delle Cave, Vincenzo Desiderio, Luigi Mele, Michele Caraglia, Giovanna Cacciapuoti, Marina Porcelli

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Antitumoral Activity of the Universal Methyl DonorMolecules (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. [Heat stress induces neuronal apoptosis by up-regulating endoplasmic reticulum stress pathway].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. βCell death & disease · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Laura MoscaDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Martina PaganoDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Concetta Paola IlissoDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Donatella Delle CaveDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Vincenzo DesiderioDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0003-1819-6083
Luigi MeleDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Michele CaragliaDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.ORCID 0000-0003-2408-6091
Giovanna CacciapuotiDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
Marina PorcelliDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
University of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

S-Adenosyl-l-methionine (AdoMet) is a naturally and widely occurring sulfonium compound that plays a primary role in cell metabolism and acts as the principal methyl donor in many methylation reactions. AdoMet also exhibits antiproliferative and proapoptotic activities in different cancer cells. However, the molecular mechanisms underlying the effects exerted by AdoMet have only been partially studied. In the current study, we evaluated the antiproliferative effect of AdoMet on Cal-33 oral and JHU-SCC-011 laryngeal squamous cancer cells to define the underlying mechanisms. We demonstrated that AdoMet induced apoptosis in Cal-33 and JHU-SCC-011 cells, involving a caspase-dependent mechanism paralleled by an increased Bax/Bcl-2 ratio. Moreover, we showed, for the first time, that AdoMet induced ER-stress in Cal-33 cells and activated the unfolded protein response, which can be responsible for apoptosis induction through the activation of CHOP and JNK. In addition, AdoMet-induced ER-stress was followed by autophagy with a consistent increase in the levels of the autophagic marker LC3B-II, which was indeed potentiated by the autophago-lysosome inhibitor chloroquine. As both escape from apoptosis and decreased activation of JNK are mechanisms of resistance to cisplatin (cDPP), an agent usually used in cancer therapy, we have evaluated the effects of AdoMet in combination with cDPP on Cal-33 cells. Our data showed that the combined treatment resulted in a strong synergism in inhibiting cell proliferation and in enhancing apoptosis via intrinsic mechanism. These results demonstrate that AdoMet has ER-stress-mediated antiproliferative activity and synergizes with cDDP on cell growth inhibition, thus providing the basis for its use in new anticancer strategies.

Indexed as

Antineoplastic AgentsApoptosisAutophagyCell Line, TumorCell ProliferationCisplatinDrug Resistance, NeoplasmDrug SynergismEndoplasmic Reticulum StressHumansS-AdenosylmethionineSquamous Cell Carcinoma of Head and NeckAntineoplastic AgentsCisplatinS-Adenosylmethionineapoptosisautophagycisplatindrug combinationER-stresshuman head and neck cancer cellsS-Adenosylmethionine

Identifiers

PMID30575033
PMCPMC13483283
OpenAlexW2905749106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.